1
|
Khider L, Soudet S, Laneelle D, Boge G, Bura-Rivière A, Constans J, Dadon M, Desmurs-Clavel H, Diard A, Elias A, Emmerich J, Galanaud JP, Giordana P, Gracia S, Hamade A, Jurus C, Le Hello C, Long A, Michon-Pasturel U, Mirault T, Miserey G, Perez-Martin A, Pernod G, Quere I, Sprynger M, Stephan D, Wahl D, Zuily S, Mahe G, Sevestre MA. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19. J Med Vasc 2020; 45:210-213. [PMID: 32571561 PMCID: PMC7183940 DOI: 10.1016/j.jdmv.2020.04.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 04/17/2020] [Indexed: 01/08/2023]
Affiliation(s)
- L Khider
- Vascular Medicine department, Georges-Pompidou European Hospital, Paris University, AP-HP, 75015 Paris, France
| | - S Soudet
- Vascular Medicine department, University Hospital Amiens Picardie, 80000 Amiens, France
| | - D Laneelle
- Vascular Medicine department, University Hospital of Caen-Normandie, 14000 Caen, France
| | - G Boge
- Vascular Medicine unit, Department of Internal Medicine, Montpellier University Hospital, 34000 Montpellier cedex 5, France
| | - A Bura-Rivière
- Vascular Medicine department, CHU of Rangueil, 31059 Toulouse cedex 9, France
| | - J Constans
- Vascular Medicine department, Saint-André Hospital, 33075 Bordeaux cedex, France
| | - M Dadon
- Vascular Medicine department, Paris Saint-Joseph Hospital Group, 75014 Paris, France
| | - H Desmurs-Clavel
- Internal Medicine department, Hospital Edouard-Herriot, 69003 Lyon, France
| | - A Diard
- Vascular Medicine office, 33550 Langoiran, France
| | - A Elias
- Vascular Medicine department, Sainte-Musse Hospital Center, 83100 Toulon, France
| | - J Emmerich
- Vascular Medicine department, Paris Saint-Joseph Hospital Group, 75014 Paris, France; Paris Descartes University, Paris, France
| | - J-P Galanaud
- Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, M4N 3M5 Toronto, ON, Canada
| | - P Giordana
- Vascular Medicine office, 06000 Nice, France
| | - S Gracia
- Vascular Medicine office, 17138 Puilboreau, France
| | - A Hamade
- Vascular Medicine unit, Emile-Muller Hospital, 68070 Mulhouse cedex 01, France
| | - C Jurus
- Vascular Medicine department, Tonkin Clinic, 69100 Villeurbanne, France
| | - C Le Hello
- Vascular Medicine department, University Hospital of Saint-Étienne, 42000 Saint-Étienne, France
| | - A Long
- Vascular Medicine department, Edouard-Herriot Hospital, 69003 Lyon, France
| | - U Michon-Pasturel
- Vascular Medicine department, Paris Saint-Joseph Hospital Group, 75014 Paris, France; Paris Descartes University, Paris, France
| | - T Mirault
- Vascular Medicine department, Georges-Pompidou European Hospital, Paris University, AP-HP, 75015 Paris, France
| | - G Miserey
- Vascular Medicine office, 78120 Rambouillet, France
| | - A Perez-Martin
- Vascular Medicine department, University hospital of Nîmes, 30000 Nîmes, France
| | - G Pernod
- Vascular Medicine department, Grenoble-Alpes University Hospital, 38000 Grenoble, France
| | - I Quere
- Vascular Medicine unit, Department of Internal Medicine, Montpellier University Hospital, 34000 Montpellier cedex 5, France
| | - M Sprynger
- Department of Cardiology, University Hospital of Liège, 4000 Liège, Belgium
| | - D Stephan
- Hypertension and Vascular Medicine department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
| | - D Wahl
- Vascular Medicine Division and Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, 54000 Nancy, France
| | - S Zuily
- Vascular Medicine departement, University hospital of Rennes, 35000 Rennes, France
| | - G Mahe
- Vascular Medicine departement, University hospital of Rennes, 35000 Rennes, France
| | - M A Sevestre
- Vascular Medicine department, University Hospital Amiens Picardie, 80000 Amiens, France.
| | | |
Collapse
|
2
|
Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G. [Not Available]. J Med Vasc 2019; 44:307-308. [PMID: 31213305 DOI: 10.1016/j.jdmv.2019.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- I Quéré
- Service de médecine vasculaire, CHU Montpellier, 80, avenue Augustun-Fliche, 34090 Montpellier, France
| | - A Elias
- Service de médecine vasculaire, centre hospitalier Sainte Musse, 83100 Toulon, France
| | - M Maufus
- Service de médecine vasculaire, centre hospitalier Pierre Oudot, 38300 Bourgoin-Jallieu, France
| | - M Elias
- Service de médecine vasculaire, centre hospitalier Sainte Musse, 83100 Toulon, France
| | - M-A Sevestre
- Service de médecine vasculaire, CHU Amiens Picardie, avenue Laennec, 80054 Amiens cedex 1, France
| | - J-P Galanaud
- Département de médecine, Sunnybrook Health Sciences Centre, université de Toronto, Toronto, Canada
| | - J-L Bosson
- Département de biostatistiques, CHU Grenoble-Alpes, 38700 La Tronche, France
| | - A Bura-Rivière
- Service de médecine vasculaire, CHU Rangueil, 31059 Toulouse cedex 9, France
| | - C Jurus
- Service de médecine vasculaire, clinique du Tonkin, 69100 Villeurbanne, France
| | - P Lacroix
- Service de médecine vasculaire, hôpital Dupuytren, CHU Limoges, 87042 Limoges cedex, France
| | - S Zuily
- Service de médecine vasculaire, hôpital Brabois, CHU Nancy, 54511 Vandœuvre-lès-Nancy cedex, France
| | - A Diard
- Médecine vasculaire, 25, route de Créon, 33550 Langoiran, France
| | - D Wahl
- Service de médecine vasculaire, hôpital Brabois, CHU Nancy, 54511 Vandœuvre-lès-Nancy cedex, France
| | - L Bertoletti
- Service de médecine vasculaire et thérapeutique, hôpital Nord, CHU St.-Étienne, 42, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France
| | - D Brisot
- Médecine vasculaire, 34830 Clapiers, France
| | - P Frappe
- Département de médecine générale, université Jean-Monnet, 42000 St.-Étienne, France
| | - J-L Gillet
- Médecine vasculaire, 1328, avenue Maison-Blanche, 38300 Bourgoin-Jallieu, France
| | - P Ouvry
- Médecine vasculaire, 1328, avenue Maison-Blanche, 76550 Saint-Aubin-sur-Scie, France
| | - G Pernod
- Service de médecine vasculaire, CHU Grenoble-Alpes, avenue Maquis-du-Grésivaudan, 38043 Grenoble, France.
| |
Collapse
|
3
|
Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G. [Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)]. J Med Vasc 2019; 44:e1-e47. [PMID: 30770089 DOI: 10.1016/j.jdmv.2018.12.178] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- I Quéré
- Service de médecine vasculaire, CHU Montpellier, 80, avenue Augustun-Fliche, 34090 Montpellier, France
| | - A Elias
- Service de médecine vasculaire, CH Sainte Musse, 83100 Toulon, France
| | - M Maufus
- Service de médecine vasculaire, CH Pierre Oudot, 38300 Bourgoin-Jallieu, France
| | - M Elias
- Service de médecine vasculaire, CH Sainte Musse, 83100 Toulon, France
| | - M-A Sevestre
- Service de médecine vasculaire, CHU Amiens-Picardie, Avenue Laennec, 80054 Amiens cedex 1, France
| | - J-P Galanaud
- Département de médecine, Sunnybrook Health Sciences Centre, université de Toronto, Toronto, Canada
| | - J-L Bosson
- Département de biostatistiques, CHU Grenoble-Alpes, 38043 Grenoble, France
| | - A Bura-Rivière
- Service de médecine vasculaire, CHU Rangueil, 31059 Toulouse cedex 9, France
| | - C Jurus
- Service de médecine vasculaire, clinique du Tonkin, 69100 Villeurbanne, France
| | - P Lacroix
- Service de médecine vasculaire, Hôpital Dupuytren, CHU Limoges, 87042 Limoges cedex, France
| | - S Zuily
- Service de médecine vasculaire, Hôpital Brabois, CHU Nancy, 54511 Vandoeuvre-Les-Nancy cedex, France
| | - A Diard
- Médecine vasculaire, 25, route de Créon, 33550 Langoiran, France
| | - D Wahl
- Service de médecine vasculaire, Hôpital Brabois, CHU Nancy, 54511 Vandoeuvre-Les-Nancy cedex, France
| | - L Bertoletti
- Service de médecine vasculaire et thérapeutique, Hôpital Nord, CHU St-Étienne, 42, avenue Albert Raimond, 42270 Saint-Priest-en-Jarez, France
| | - D Brisot
- Médecine vasculaire, 34830 Clapiers, France
| | - P Frappe
- Département de médecine générale, université Jean-Monnet, 42000 St-Étienne, France
| | - J-L Gillet
- Médecine vasculaire, 38300 Bourgoin-Jallieu, France
| | - P Ouvry
- Médecine vasculaire, 1328, avenue de la Maison Blanche, 76550 Saint-Aubin-sur-Scie, France
| | - G Pernod
- Service de médecine vasculaire, CHU Grenoble-Alpes, 38043 Grenoble, France.
| |
Collapse
|
4
|
Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G. Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV). J Med Vasc 2019; 44:28-70. [PMID: 30770082 DOI: 10.1016/j.jdmv.2018.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Accepted: 12/01/2018] [Indexed: 06/09/2023]
Affiliation(s)
- I Quéré
- Service de médecine vasculaire, CHU Montpellier, 80, avenue Augustun-Fliche, 34090 Montpellier, France
| | - A Elias
- Service de médecine vasculaire, CH Sainte Musse, 83100 Toulon, France
| | - M Maufus
- Service de médecine vasculaire, CH Pierre Oudot, 38300 Bourgoin-Jallieu, France
| | - M Elias
- Service de médecine vasculaire, CH Sainte Musse, 83100 Toulon, France
| | - M-A Sevestre
- Service de médecine vasculaire, CHU Amiens Picardie, avenue Laennec, 80054 Amiens cedex 1, France
| | - J-P Galanaud
- Département de médecine, Sunnybrook Health Sciences Centre, université de Toronto, Toronto, Canada
| | - J-L Bosson
- Département de biostatistiques, CHU Grenoble-Alpes, 38700 La Tronche, France
| | - A Bura-Rivière
- Service de médecine vasculaire, CHU Rangueil, 31059 Toulouse cedex 9, France
| | - C Jurus
- Service de médecine vasculaire, clinique du Tonkin, 69100 Villeurbanne, France
| | - P Lacroix
- Service de médecine vasculaire, hôpital Dupuytren, CHU Limoges, 87042 Limoges cedex, France
| | - S Zuily
- Service de médecine vasculaire, hôpital Brabois, CHU Nancy, 54511 Vandoeuvre-les-Nancy cedex, France
| | - A Diard
- Médecine vasculaire, 25, route de Créon, 33550 Langoiran, France
| | - D Wahl
- Service de médecine vasculaire, hôpital Brabois, CHU Nancy, 54511 Vandoeuvre-les-Nancy cedex, France
| | - L Bertoletti
- Service de médecine vasculaire et thérapeutique, hôpital Nord, CHU St.-Étienne, 42, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France
| | - D Brisot
- Médecine vasculaire, 34830 Clapiers, France
| | - P Frappe
- Département de médecine générale, université Jean-Monnet, 42000 St.-Étienne, France
| | - J-L Gillet
- Médecine vasculaire, 1328, avenue Maison-Blanche, 38300 Bourgoin-Jallieu, France
| | - P Ouvry
- Médecine vasculaire, 1328, avenue Maison-Blanche, 76550 Saint-Aubin-sur-Scie, France
| | - G Pernod
- Service de médecine vasculaire, CHU Grenoble-Alpes, avenue Maquis-du-Grésivaudan, 38043 Grenoble, France.
| |
Collapse
|
5
|
Laroche JP, Blaise S, Becker F, Laaeng Massoni C, Nou-Howaldt M, Pichot O, Desmurs-Clavel H, Jeancolas J, Jurus C, Sarlon-Bartoli G, Soulier-Sotto V, Thiel H, Sevestre-Pietri MA, Maloizel-Delaunay J, Mestre-Godin S. [Quality standards for ultrasonographic assessment of peripheral vascular malformations and vascular tumors. Report of the french society for vascular medicine. 2018 Update]. J Med Vasc 2018; 43:36-51. [PMID: 29425539 DOI: 10.1016/j.jdmv.2017.11.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Accepted: 11/02/2017] [Indexed: 06/08/2023]
Abstract
UNLABELLED The quality standards of the French Society of Vascular Medicine for the ultrasonographic assessment of vascular malformations are based on the two following requirements: (1) technical know-how: mastering the use of ultrasound devices and the method of examination; (2) medical know-how: ability to adapt the methods and scope of the examination to its clinical indication and purpose, and to rationally analyze and interpret its results. AIMS OF THE QUALITY STANDARDS To describe an optimal method of examination in relation to the clinical question and hypothesis. To homogenize practice, methods, glossary, and reporting. To provide good practice reference points, and promote a quality process. ITEMS OF THE QUALITY STANDARDS The 3 levels of examination; their clinical indications and goals. The reference standard examination (level 2), its variants according to clinical needs. The minimal content of the examination report; the letter to the referring physician (synthesis, conclusion and proposal for further investigation and/or therapeutic management). Commented glossary (anatomy, hemodynamics, semiology). Technical bases. Setting and use of ultrasound devices. Here, we discuss ultrasonography methods of using of ultrasonography for the assessment of peripheral vascular malformations and tumors (limbs, face, trunk).
Collapse
MESH Headings
- Adult
- Blood Coagulation Disorders/blood
- Blood Coagulation Disorders/etiology
- Blood Flow Velocity
- Clinical Competence
- Disease Progression
- Eye Neoplasms/diagnostic imaging
- Female
- Fibrin Fibrinogen Degradation Products/analysis
- Fibrinogen/analysis
- Hemangioma/diagnostic imaging
- Hemodynamics
- Humans
- Infant
- Lymphangioma, Cystic/diagnostic imaging
- Male
- Quality Assurance, Health Care
- Ultrasonography, Doppler, Color/instrumentation
- Ultrasonography, Doppler, Color/methods
- Ultrasonography, Doppler, Duplex/instrumentation
- Ultrasonography, Doppler, Duplex/methods
- Ultrasonography, Doppler, Duplex/standards
- Vascular Malformations/blood
- Vascular Malformations/classification
- Vascular Malformations/complications
- Vascular Malformations/diagnostic imaging
- Vascular Neoplasms/diagnostic imaging
Collapse
Affiliation(s)
- J P Laroche
- Médecine vasculaire, médecine interne B, hôpital Saint-Eloi, CHU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - S Blaise
- Département de médecine vasculaire, CHU Grenoble Alpes, 38000 Grenoble, France.
| | - F Becker
- Service d'angiologie et d'hémostase, hôpitaux universitaires de Genève, hôpital Cantonal, 1205 Genève, Suisse
| | | | - M Nou-Howaldt
- Médecine vasculaire, médecine interne B, hôpital Saint-Eloi, CHU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - O Pichot
- Département de médecine vasculaire, CHU Grenoble Alpes, 38000 Grenoble, France
| | - H Desmurs-Clavel
- Hospices civils de Lyon, service de médecine interne, hôpital Édouard-Herriot, 5, rue d'Arsonval, 69437 Lyon, France
| | - J Jeancolas
- Médecine vasculaire, CHU Caen, avenue de la Côte de Nacre, 14033 Caen, France
| | - C Jurus
- Médecine vasculaire, clinique du Tonkin, 26, rue du Tonkin, 69100 Villeurbanne, France
| | - G Sarlon-Bartoli
- Médecine vasculaire, CHU La Timone, 264, rue Saint-Pierre, 13005 Marseille, France
| | - V Soulier-Sotto
- Médecine vasculaire, médecine interne B, hôpital Saint-Eloi, CHU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - H Thiel
- Médecine vasculaire, CHU Clermont-Ferrand, hôpital Gabriel-Montpied, 58, rue Montalembert, 63003 Clermont-Ferrand, France
| | - M A Sevestre-Pietri
- Médecine vasculaire, Site Sud, CHU d'Amiens-Picardie, 80054 Amiens cedex 1, France
| | - J Maloizel-Delaunay
- Médecine vasculaire, CHU Rangueil, 1, avenue du Professeur Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - S Mestre-Godin
- Département de médecine vasculaire, CHU Grenoble Alpes, 38000 Grenoble, France
| |
Collapse
|
6
|
Galanaud JP, Sevestre MA, Genty C, Kahn SR, Pernod G, Rolland C, Diard A, Dupas S, Jurus C, Diamand JM, Quere I, Bosson JL. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 2014; 12:436-43. [PMID: 24450376 DOI: 10.1111/jth.12512] [Citation(s) in RCA: 86] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2013] [Accepted: 01/16/2014] [Indexed: 11/30/2022]
Abstract
BACKGROUND Isolated distal deep vein thrombosis (iDDVT) (i.e. without proximal DVT or pulmonary embolism) represents half of all cases of lower limb DVT. Its clinical significance and management are controversial. Data on long-term follow-up are scarce, especially concerning risk and predictors of venous thromboembolism (VTE) recurrence. METHODS Using data from the OPTIMEV (OPTimisation de l'Interrogatoire dans l'évaluation du risque throMbo-Embolique Veineux) study, a prospective, observational, multicenter study, we compared, 3 years after an index VTE event and after discontinuation of anticoagulants, (i) the incidence and type of recurrence in patients without cancer with a first iDDVT vs. a first isolated proximal DVT (iPDVT) and (ii) predictors of recurrence after iDDVT. RESULTS Compared with patients with iPDVT (n = 259), patients with an iDDVT (n = 490) had a lower annualized incidence of overall VTE recurrence (5.2% [95% confidence interval 3.6-7.6] vs. 2.7% [1.9-3.8], respectively; P = 0.02) but a similar incidence of pulmonary embolism recurrence (1.0% [0.5-2.3] vs. 0.9% [0.5-1.6], respectively; P = 0.83). An age of > 50 years, unprovoked character of index iDDVT, and involvement of more than one vein in one or both legs each independently tripled the risk of recurrence, with the latter then being ≥ 3% per patient-year. Neither muscular vein nor deep-calf vein location of iDDVT nor clot diameter with compression influenced the risk of recurrence. CONCLUSIONS After stopping anticoagulants, patients with iDDVT have a significantly lower risk of overall VTE recurrence than did patients with iPDVT but a similar risk of serious recurrent VTE. Age > 50 years, unprovoked iDDVT, and number of thrombosed veins (more than one) influenced the risk of recurrence and may help to define patients at significant risk of recurrence.
Collapse
Affiliation(s)
- J-P Galanaud
- Clinical Investigation Center and Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Laroche JP, Becker F, Khau-Van-Kien A, Baudoin P, Brisot D, Buffler A, Coupé M, Jurus C, Mestre S, Miserey G, Soulier-Sotto V, Tissot A, Viard A, Vignes S, Quéré I. [Quality standards for ultrasonographic assessment of peripheral vascular malformations and vascular tumors. Report of the French Society for Vascular Medicine]. J Mal Vasc 2013; 38:29-42. [PMID: 23312609 DOI: 10.1016/j.jmv.2012.11.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/25/2012] [Accepted: 11/08/2012] [Indexed: 01/19/2023]
Abstract
THE QUALITY STANDARDS OF THE FRENCH SOCIETY OF VASCULAR MEDICINE FOR THE ULTRASONOGRAPHIC ASSESSMENT OF VASCULAR MALFORMATIONS ARE BASED ON THE TWO FOLLOWING REQUIREMENTS: Technical know-how: mastering the use of ultrasound devices and the method of examination. Medical know-how: ability to adapt the methods and scope of the examination to its clinical indication and purpose, and to rationally analyze and interpret its results. AIMS OF THE QUALITY STANDARDS: To describe an optimal method of examination in relation to the clinical question and hypothesis. To achieve consistent practice, methods, glossary, and reporting. To provide good practice reference points, and promote a high-quality process. ITEMS OF THE QUALITY STANDARDS: The three levels of examination; their clinical indications and goals. The reference standard examination (level 2), its variants according to clinical needs. The minimal content of the examination report; the letter to the referring physician (synthesis, conclusion and proposal for further investigation and/or therapeutic management). Commented glossary (anatomy, hemodynamics, semiology). Technical bases. Settings and use of ultrasound devices. Here, we discuss the methods of using ultrasonography for the assessment of peripheral vascular malformations and tumors.
Collapse
Affiliation(s)
- J-P Laroche
- Médecine interne B, médecine vasculaire, hôpital Saint-Éloi, CHU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Streinchenberger R, Barjoud H, Adeleine P, Larese A, Nemoz C, Chatelard P, Nedey C, Sabben F, Ganichot F, Jurus C. Venous allografts preserved at 4 degrees C for infrainguinal bypass: long-term results from 170 procedures. Ann Vasc Surg 2000; 14:553-60. [PMID: 11128448 DOI: 10.1007/s100169910103] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
From April 21, 1982 to December 31, 1997, we performed 170 infrainguinal bypass procedures using isolated (n = 35) or composite (n = 135) venous allografts preserved at 4 degrees C as a substitute for saphenous autografts in 146 patients. The mean age of the patient population was 74 years. The indication was critical lower limb ischemia in 71% of cases. Seventy-five percent of procedures were below the knee and 26% were infrapopliteal. Mean length and diameter were 19.5 +/- 0.5 cm and 4.8 +/- 0.5 mm, respectively. After December 8, 1993, a reinforcement net was placed over the graft to prevent expansion in 71% of cases. Primary and secondary 5-year patency, calculated according to the Kaplan-Meier method, were 33 +/- 6% and 43 +/- 6%, respectively. Factors correlated with secondary patency were studied using the log-rank test. Previous ipsilateral infrainguinal revascularization was associated with a 40% decrease in secondary patency at 2 years (71% vs. 31%). Patency at 5 years was correlated with the level of anastomosis (47% for low popliteal anastomosis vs. 30% for infrapopliteal anastomosis). The likelihood of stenosis or dilatation of the allograft was 8% and 29.5%, respectively, at 5 years. The 5-year limb salvage and survival rates were 84% and 57%, respectively. The encouraging results of this series suggest that venous allografts provide a useful alternative for infrainguinal bypass when autologous grafts or other more reliable conduits are unavailable.
Collapse
|
9
|
Nedey C, Barjoud H, Chatelard P, Pizza E, Brunon AM, Adeleine P, Sabben F, Ganichot F, Jurus C, Chatel C. The role of intraoperative transcranial Doppler monitoring in carotid artery surgery. Ann Vasc Surg 1995; 9:247-51. [PMID: 7632552 DOI: 10.1007/bf02135283] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Of 135 carotid artery reconstructions performed under general anesthesia in 127 patients (mean age 68 years), 119 were performed with continuous intraoperative Doppler recording of the middle cerebral artery. This investigation was impossible in nine (6.7%) cases because of the absence of a visible temporal window, and results were deemed uninterpretable in six (4.5%) additional cases. The goals of this study were to test the feasibility and reliability of transcranial Doppler monitoring in the evaluation of intracranial perfusion and to determine the risk of cerebral ischemia during carotid artery clamping. The two outcome parameters measured were mean velocity and percentage of decreased flow in the middle cerebral artery during clamping. Patients were divided into four groups based on variations in these parameters. Groups I and IIA (low risk) represented 69.7% of cases, group IIB (significant risk) represented 21.9%, and group III (major risk) represented 8.4%. Transcranial Doppler monitoring appears to be a reliable means of observing middle cerebral artery flow during carotid surgery and in our opinion provides objective criteria for determining the need for an indwelling shunt. Accordingly, in this study no neurologic complications imputable to clamping were observed. Transcranial Doppler monitoring can also be used to ensure correct functioning of the shunt and to detect intraoperative embolic complications.
Collapse
Affiliation(s)
- C Nedey
- Département d'Anesthésie-Réanimation, Clinique du Tonkin, Villeurbanne, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Fresard A, Jurus C, Muron T, Bertrand J, Peyramond D, Lucht F. Prophylaxie de la pneumocystose au cours de l'infection par le VIH par aérosol de pentamidine : comparaison de la tolérance en fonction du type de nébuliseur : Respirgard II versus Atomisor NL5F. Med Mal Infect 1994. [DOI: 10.1016/s0399-077x(05)80561-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
11
|
Hanss M, Trzeciak M, Ninet J, Jurus C, Boulieu D, Dechavanne M. Decreased plasma fibrin degradation products during hormonal stimulation for in vitro fertilisation. ACTA ACUST UNITED AC 1993. [DOI: 10.1016/0268-9499(93)90151-k] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|